• Beutler, B.A., Milsark, I.W. and Cerami, A. (1985) Cachectin/tumor necrosis factor: Production, distribution and metabolic fate in vivo. J. Immunol. 135, 39723977.
  • Brown, R.A. and Beck, J.S. (1990) Medical Statistics on Microcomputers. British Medical Journal, London.
  • Calandra, T., Baumgartner, J.D., Grau, G.E., Wu, M.M., Lambert, P.H., Schellekens, J., Verhoef, J., Glauser, M. P. and The Swiss-Dutch Immunoglobulin Study Group (1990) Prognosis values for tumor necrosis factor/cachectin, interleukin-1, alpha interferon and gamma interferon in the serum of patients with septic shock. J. infect. Dis. 161, 982987.
  • Cerami, A. and Beutler, B. (1988) The role of cachectin/TNF in endotoxic shock and cachexia. Immunol. Today 9, 2831.
  • Echtenacher, B., Falk, W., Mannel, D.N. and Krammer, P.H. (1990) Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol. 145, 37623766.
  • Gearing, A.J.H., Bird, C.R., Bristow, A., Poole, S. and Thorpe, R. (1987) A simple sensitive bioassay for interleukin 1 which is unresponsive to 103 units/ml of interleukin 2. J. immunol. Methods 99, 711.
  • Hesse, D.G., Tracey, K.J., Fong, Y., Manogue, K.R., Palladino, M.A., Cerami, A., Shires, G.T. and Lowry, S.F. (1988) Cytokine appearance in human endotoxemia and primate bacteremia. Surg. Gynecol. Obstet. 166, 147153.
  • King, J.N. and Gerring, E.L. (1988) Detection of endotoxin in cases of equine colic. Vet. Rec. 123, 269271.
  • King, J.N. and Gerring, E.L. (1991) The action of low dose endotoxin on equine bowel motility. Equine vet. J. 23, 1117.
  • May, S.A., Hooke, R.E. and Lees, P. (1990) The characterisation of equine interleukin-1. Vet. Immunol. Immunopathol. 24, 169175.
  • Mitchie, H.R., Manogue, K.R., Spriggs, D.R., Revhaug, A., O'Dwyer, S., Dinarello, C.A., Cerami, A., Wolff, S.M. and Wilmore, D.W. (1988) Detection of circulating tumor necrosis factor after endotoxin administration. New Engl. J. Med. 318, 14811486.
  • Morris, D.D., Crow, N. and Moore, J.N. (1990) Correlation of clinical and laboratory data with serum tumor necrosis factor activity in horses with experimentally induced endotoxemia. Am. J. vet. Res. 51, 19351940.
  • Morris, D.D., Moore, J.N. and Crowe, N. (1991) Serum tumor necrosis factor activity in horses with colic attributable to gastrointestinal tract disease. Am. J. vet. Res. 52, 15651569.
  • Renz, H., Gong, J.H., Schmidt, A., Nain, M. and Gemsa, D. (1988) Release of tumor necrosis factor-α from macrophages. J. Immunol. 141, 23882393.
  • Scuderi, P., Sterling, K.E., Lam, K. S. Finley, P. R., Ryan, K.J., Ray, C.G., Petersen, E., Slymen, D.J. and Salmon, S.E. (1986) Raised serum levels of tumour necrosis factor in parasitic infections. Lancet ii, 13641365.
  • Seenathan, P., Bottoms, G.D. and Schafter, K. (1990) Characterization of release of tumor necrosis factor, interleukin-1, and superoxide anion from equine white blood cells in response to endotoxin. Am. J. vet. Res. 51, 12211225.
  • Templeton, C.B., Bottoms, G. D., Fessler, J. F., Turek, J. J. and Boon, G.D. (1985) Effects of repeated endotoxin injection on prostanoids, haemodynamics, endothelial cells and survival in ponies. Circ. Shock 16, 253264.
  • Tracey, K.K., Beutler, B., Lowry, S.F., Merryweather, J., Wolpe, S., Milsark, I.W., Hariri, R.J., Fahey, T.J., Zentella, A., Albert, J.D., Shires, G.T. and Cerami, A. (1986) Shock and tissue injury induced by recombinant human cachectin. Science, NY 234, 470474.
  • Tracey, K.J., Fong, Y., Hesse, D.G., Manogue, K.R., Lee, A.T., Kuo, G.C., Lowry, S.F. and Cerami, A. (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature, Lond. 330, 662664.
  • Tracey, K.J., Vlassara, H. and Cerami, A. (1989) Cachectin/tumour necrosis factor. Lancet, i, 11221126.
  • Waage, A., Halstensen, A. and Espevik, T. (1987) Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet, i, 355357.